RxDoctor Payments Data

Yong Kim, MD

Orthopaedic Surgery of the Spine · New York, NYNPI 1720053184

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $80,818 of the $110,661 with a category attached, or 73.0%. 17 manufacturers reported payments, led by Zimmer Biomet at 49.6% of the total. Reporting peaked in 2019 at $46,492 and has fallen 90.9% since, to $4,222 in 2025.

$110,661in general payments, 2019–2025

Across 102 payments — averaging $1084.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$55K
  • Altus Partners. LLC$35K
  • Zimvie Inc.$7K
  • Highridge Medical LLC$6K
  • Gotham Surgical Solutions & Devices, Inc.$3K
  • Globus Medical$2K
  • plus $4K from 11 others
$104,212in ownership & investment interests, 2019–2025

Across 12 payments — averaging $8684.35 each. An ownership or investment interest held by the physician or an immediate family member.

  • Amplify Surgical, Inc.$54K
  • Happe Spine$50K

What the payments were for

  • Royalty or licence$80,81873%
  • Consulting fees$18,75017%
  • Travel & lodging$2,8263%
  • Food & beverage$5,8675%
  • Education$2,4002%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$110,661 in reported general payments places this provider in the 80th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York

Medicare billing

Part B allowed, 2024
$174,281
Medicare patients
293
Services billed
766

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib16$1,840
Gabapentin145$980
Diclofenac Sodium55$591
Tizanidine Hcl29$209
Methylprednisolone14$119
Cyclobenzaprine Hcl36$111
Tramadol Hcl15$62

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →